You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
68 Picard, Silvy, and Gabert<br />
63. Martinelli, G., Buonamici, S., Visani, G., et al. (2003) Molecular monitoring of<br />
acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11<br />
transcript copy number above which relapse occurs and below which continuous<br />
complete remission is likely. <strong>Leukemia</strong> 17, 650–651.<br />
64. Scholl, C., Breitinger, H., Schlenk, R. F., Dohner, H., Frohling, S., and Dohner,<br />
K. (2003) AML Study Group Ulm. Development of a real-time RT-PCR assay for<br />
the quantification of the most frequent MLL/AF9 fusion types resulting from<br />
translocation t(9;11)(p22;q23) in acute myeloid leukemia. Genes Chromosomes<br />
Cancer 38, 274–280.<br />
65. Viehmann, S., Teigler-Schlegel, A., Bruch, J., Langebrake, C., Reinhardt, D., and<br />
Harbott, J. (2003) Monitoring of minimal residual disease (MRD) by real-time<br />
quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid<br />
leukemia with AML1/ETO rearrangement. <strong>Leukemia</strong> 17, 1130–1136.<br />
66. Satake, N., Maseki, N., Kozu, T., et al. (1995) Disappearance of AML1-<br />
MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in<br />
long-term remission. Br. J. Haematol. 91, 892–898.
Change language